Literature DB >> 11739823

Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS.

S C Bourke1, P J Shaw, G J Gibson.   

Abstract

BACKGROUND: Most patients with ALS have evidence of respiratory muscle weakness at diagnosis, and death is usually due to respiratory failure. Sleep disruption, possibly due to apneas, hypopneas, orthopnea, or REM-related desaturation, is common. The relative impact of these factors on quality of life has not been established.
METHODS: The authors recruited 23 subjects with probable or definite ALS. Quality of life was assessed using generic and specific instruments, and respiratory muscle strength by measurement of vital capacity, maximum static pressures, and sniff nasal inspiratory pressure. Twenty-two subjects underwent polysomnography. Overall limb and axial muscle strength was estimated using a summated muscle score based on the Medical Research Council clinical scale.
RESULTS: On univariate analysis, there were moderate to strong correlations between quality of life and all measurements of respiratory muscle function (R = 0.42-0.82). The correlations with selected polysomnographic indices were weaker and less consistent (R = 0.44-0.59). Multivariate analysis showed that maximum static inspiratory pressure was the strongest independent predictor of quality of life.
CONCLUSION: Quality of life was strongly and independently related to respiratory muscle function. Relations with polysomnographic indices were weaker and were attributable to respiratory muscle weakness. Respiratory muscle weakness is much more important than the frequency of apneas and hypopneas in determining quality of life in ALS.

Entities:  

Mesh:

Year:  2001        PMID: 11739823     DOI: 10.1212/wnl.57.11.2040

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

1.  Neither serotonin nor adenosine-dependent mechanisms preserve ventilatory capacity in ALS rats.

Authors:  N L Nichols; R A Johnson; I Satriotomo; G S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2014-03-28       Impact factor: 1.931

Review 2.  Mechanisms of compensatory plasticity for respiratory motor neuron death.

Authors:  Yasin B Seven; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2019-01-06       Impact factor: 1.931

3.  Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia.

Authors:  S Ward; M Chatwin; S Heather; A K Simonds
Journal:  Thorax       Date:  2005-12       Impact factor: 9.139

4.  Mechanisms of Enhanced Phrenic Long-Term Facilitation in SOD1G93A Rats.

Authors:  Nicole L Nichols; Irawan Satriotomo; Latoya L Allen; Ashley M Grebe; Gordon S Mitchell
Journal:  J Neurosci       Date:  2017-05-12       Impact factor: 6.167

Review 5.  Sleep-disordered breathing in neurodegenerative diseases.

Authors:  Carles Gaig; Alex Iranzo
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

6.  5-HT2A/B receptor expression in the phrenic motor nucleus in a rat model of ALS (SOD1G93A).

Authors:  Lauren F Borkowski; Taylor A Craig; Olivia E Stricklin; Katherine A Johnson; Nicole L Nichols
Journal:  Respir Physiol Neurobiol       Date:  2020-06-03       Impact factor: 1.931

Review 7.  Neuromuscular disorders and sleep.

Authors:  Ibrahim Oztura; Christian Guilleminault
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

8.  Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis.

Authors:  Nicole L Nichols; Genevieve Gowing; Irawan Satriotomo; Lisa J Nashold; Erica A Dale; Masatoshi Suzuki; Pablo Avalos; Patrick L Mulcrone; Jacalyn McHugh; Clive N Svendsen; Gordon S Mitchell
Journal:  Am J Respir Crit Care Med       Date:  2012-12-06       Impact factor: 21.405

9.  Acute intermittent hypoxia induced phrenic long-term facilitation despite increased SOD1 expression in a rat model of ALS.

Authors:  Nicole L Nichols; Irawan Satriotomo; Daniel J Harrigan; Gordon S Mitchell
Journal:  Exp Neurol       Date:  2015-08-16       Impact factor: 5.330

Review 10.  The management of amyotrophic lateral sclerosis.

Authors:  Julie Phukan; Orla Hardiman
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.